Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer
Clinical trial NCT04047758 · UNKNOWN
Trial details
- NCT number
- NCT04047758
- Sponsor
- Shengjing Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2021-09-30
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.